Astellas Pharma Inc. - Gross Profit

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Gross-Profit" stands at 1.57 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Astellas Pharma Inc.'s second quarter result of 0.3861 Trillion JPY for the item "Gross Profit" represents a decrease of -6.06 percent compared to it's first quarter result.

Also, Astellas Pharma Inc.'s second quarter result of 0.3861 Trillion JPY for the item "Gross Profit" represents an increase of 11.72 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s second quarter result of 1.57 Trillion JPY for the item "Gross Profit" represents an increase of 2.66 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 13.27 percent compared to the value the year prior.
The 1 year change in percent is 13.27.
The 3 year change in percent is 38.96.
The 5 year change in percent is 55.27.
The 10 year change in percent is 56.92.

The Serie's long term average value is 1.02 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 53.25 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2012, to it's latest available value, on 09/30/2025, is +145.43%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.